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The RESCUE-ICP Trial was one of the most eagerly 
awaited trials in recent history of neurosurgery. The trial 
aimed to evaluate the effectiveness of Decompressive 
Craniectomy (DC) through a randomized, control 
methodology. Herein, we would like to share the 
abstract of the trial, and a few comments with regards 
to its possible shortcomings. 
ABSTRACT
Trial of Decompressive Craniectomy for Traumatic 
Intracranial Hypertension
Peter J. Hutchinson, Angelos G. Kolias, Ivan S. 
Timofeev, Elizabeth A. Corteen, Marek Czosnyka, and 
other RESCUEicp Trial Collaborators
N Engl J Med 2016; 375:1119-1130September 22, 
2016DOI: 10.1056/NEJMoa1605215
BACKGROUND
The effect of decompressive craniectomy on clinical 
outcomes in patients with refractory traumatic 
intracranial hypertension remains unclear. Methods: 
From 2004 through 2014, we randomly assigned 408 
patients, 10 to 65 years of age, with traumatic brain 
injury and refractory elevated intracranial pressure 
(>25 mm Hg) to undergo decompressive craniectomy 
or receive ongoing medical care. The primary outcome 
was the rating on the Extended Glasgow Outcome 
Scale (GOS-E) (an 8-point scale, ranging from death to 
“upper good recovery” [no injury-related problems]) at 
6 months. The primary-outcome measure was analyzed 
with an ordinal method based on the proportional-odds 
model. If the model was rejected, that would indicate a 
significant difference in the GOS-E distribution, and 
results would be reported descriptively. Results: The 
GOS-E distribution differed between the two groups 
(P<0.001). The proportional-odds assumption was 
rejected, and therefore results are reported 
descriptively. At 6 months, the GOS-E distributions were 
as follows: death, 26.9% among 201 patients in the 
surgical group versus 48.9% among 188 patients in 
the medical group; vegetative state, 8.5% versus 2.1%; 
lower severe disability (dependent on others for care), 
21.9% versus 14.4%; upper severe disability 
(independent at home), 15.4% versus 8.0%; moderate 
disability, 23.4% versus 19.7%; and good recovery, 
4.0% versus 6.9%. At 12 months, the GOS-E 
distributions were as follows: death, 30.4% among 194 
surgical patients versus 52.0% among 179 medical 
patients; vegetative state, 6.2% versus 1.7%; lower 
severe disability, 18.0% versus 14.0%; upper severe 
disability, 13.4% versus 3.9%; moderate disability, 
22.2% versus 20.1%; and good recovery, 9.8% versus 
8.4%. Surgical patients had fewer hours than medical 
patients with intracranial pressure above 25 mm Hg 
after randomization (median, 5.0 vs. 17.0 hours; 
P<0.001) but had a higher rate of adverse events 
(16.3% vs. 9.2%, P=0.03). Conclusions: At 6 months, 
decompressive craniectomy in patients with traumatic 
brain injury and refractory intracranial hypertension 
resulted in lower mortality and higher rates of 
vegetative state, lower severe disability, and upper 
severe disability than medical care. The rates of 
moderate disability and good recovery were similar in 
the two groups. (Funded by the Medical Research 
Council and others; RESCUEicp Current Controlled 
Trials number, ISRCTN66202560.)
CRITIQUE
Although much was expected from this trial, it 
unfortunately failed to answer most questions that 
arose from DECRA. It however did help to endorse what 
the larger fraternity of neurosurgeons already 
suspected. The critiques have pointed out that the 
researchers have largely ignored to consider including 
cranioplasty in the analysis, that almost all survivors of 
DC will have to undergo and carries very high morbidity. 
It is essential to consider this procedure with DC while 
making comparisons with non-operative management 
while analyzing the cost, and 24-month outcomes, 
which they later plan to do.
 
Authors have also not discussed the difference in 
radiological grading of patients (an important predictors 
of outcomes). According to their results surgical group 
had much higher number of patients in class III (a 
significant p-value). This difference disappeared on pre 
randomization radiology, which could be because in a 
large number of patients (47 and 53) Marshall class is 
unknown. Can this difference affect final outcomes?
Finally, in 157 patients injury to start of stage 1 therapy 
delay, was more than 12 hours. Is this delay not too 
long for severe TBI patients? 
C O M M E N T A R Y
Muhammad Waqas1, Muhammad Shahzad Shamim1
1Section of Neurosurgery, the Aga Khan University Hospital Karachi, Pakistan 
5 7P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 1  ( 4 )  O C T   -   D E C   2 0 1 6
The RESCUE-ICP Trial was one of the most eagerly 
awaited trials in recent history of neurosurgery. The trial 
aimed to evaluate the effectiveness of Decompressive 
Craniectomy (DC) through a randomized, control 
methodology. Herein, we would like to share the 
abstract of the trial, and a few comments with regards 
to its possible shortcomings. 
ABSTRACT
Trial of Decompressive Craniectomy for Traumatic 
Intracranial Hypertension
Peter J. Hutchinson, Angelos G. Kolias, Ivan S. 
Timofeev, Elizabeth A. Corteen, Marek Czosnyka, and 
other RESCUEicp Trial Collaborators
N Engl J Med 2016; 375:1119-1130September 22, 
2016DOI: 10.1056/NEJMoa1605215
BACKGROUND
The effect of decompressive craniectomy on clinical 
outcomes in patients with refractory traumatic 
intracranial hypertension remains unclear. Methods: 
From 2004 through 2014, we randomly assigned 408 
patients, 10 to 65 years of age, with traumatic brain 
injury and refractory elevated intracranial pressure 
(>25 mm Hg) to undergo decompressive craniectomy 
or receive ongoing medical care. The primary outcome 
was the rating on the Extended Glasgow Outcome 
Scale (GOS-E) (an 8-point scale, ranging from death to 
“upper good recovery” [no injury-related problems]) at 
6 months. The primary-outcome measure was analyzed 
with an ordinal method based on the proportional-odds 
model. If the model was rejected, that would indicate a 
significant difference in the GOS-E distribution, and 
results would be reported descriptively. Results: The 
GOS-E distribution differed between the two groups 
(P<0.001). The proportional-odds assumption was 
rejected, and therefore results are reported 
descriptively. At 6 months, the GOS-E distributions were 
as follows: death, 26.9% among 201 patients in the 
surgical group versus 48.9% among 188 patients in 
the medical group; vegetative state, 8.5% versus 2.1%; 
lower severe disability (dependent on others for care), 
21.9% versus 14.4%; upper severe disability 
(independent at home), 15.4% versus 8.0%; moderate 
disability, 23.4% versus 19.7%; and good recovery, 
4.0% versus 6.9%. At 12 months, the GOS-E 
distributions were as follows: death, 30.4% among 194 
surgical patients versus 52.0% among 179 medical 
patients; vegetative state, 6.2% versus 1.7%; lower 
severe disability, 18.0% versus 14.0%; upper severe 
disability, 13.4% versus 3.9%; moderate disability, 
22.2% versus 20.1%; and good recovery, 9.8% versus 
8.4%. Surgical patients had fewer hours than medical 
patients with intracranial pressure above 25 mm Hg 
after randomization (median, 5.0 vs. 17.0 hours; 
P<0.001) but had a higher rate of adverse events 
(16.3% vs. 9.2%, P=0.03). Conclusions: At 6 months, 
decompressive craniectomy in patients with traumatic 
brain injury and refractory intracranial hypertension 
resulted in lower mortality and higher rates of 
vegetative state, lower severe disability, and upper 
severe disability than medical care. The rates of 
moderate disability and good recovery were similar in 
the two groups. (Funded by the Medical Research 
Council and others; RESCUEicp Current Controlled 
Trials number, ISRCTN66202560.)
CRITIQUE
Although much was expected from this trial, it 
unfortunately failed to answer most questions that 
arose from DECRA. It however did help to endorse what 
the larger fraternity of neurosurgeons already 
suspected. The critiques have pointed out that the 
researchers have largely ignored to consider including 
cranioplasty in the analysis, that almost all survivors of 
DC will have to undergo and carries very high morbidity. 
It is essential to consider this procedure with DC while 
making comparisons with non-operative management 
while analyzing the cost, and 24-month outcomes, 
which they later plan to do.
 
Authors have also not discussed the difference in 
radiological grading of patients (an important predictors 
of outcomes). According to their results surgical group 
had much higher number of patients in class III (a 
significant p-value). This difference disappeared on pre 
randomization radiology, which could be because in a 
large number of patients (47 and 53) Marshall class is 
unknown. Can this difference affect final outcomes?
Finally, in 157 patients injury to start of stage 1 therapy 
delay, was more than 12 hours. Is this delay not too 
long for severe TBI patients? 
Conflict of interest: Author declares no conflict of interest.
Funding disclosure: Nil
Author’s contribution:
Muhammad Waqas; Study concept and design, protocol writing, data collection, data analysis,
manuscript writing, manuscript review
Muhammad shahzad Shamim; Study concept and design, data collection, data analysis, manuscript
writing, manuscript review
5 8P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 1  ( 4 )  O C T   -   D E C   2 0 1 6
